Evidence map›Paper›PMID 34903813›Full record

ArticleScientific reports2021

Generation of mutant pigs by lipofection-mediated genome editing in embryos.

Maki Hirata, Manita Wittayarat, Zhao Namula, Quynh Anh Le, Qingyi Lin, Koki Takebayashi, Chommanart Thongkittidilok, Taro Mito, Sayuri Tomonari, Fuminori Tanihara and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Pig Genome Editing for Agriculture: Achievements and Challenges.International journal of molecular sciences · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Effects of the timing of electroporation duringVeterinary and animal science · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Maki HirataFaculty of Bioscience and Bioindustry, Tokushima University, Tokushima, Japan.
Manita WittayaratFaculty of Veterinary Science, Prince of Songkla University, Songkhla, Thailand.
Zhao NamulaFaculty of Bioscience and Bioindustry, Tokushima University, Tokushima, Japan.
Quynh Anh LeFaculty of Bioscience and Bioindustry, Tokushima University, Tokushima, Japan.
Qingyi LinFaculty of Bioscience and Bioindustry, Tokushima University, Tokushima, Japan.
Koki TakebayashiFaculty of Bioscience and Bioindustry, Tokushima University, Tokushima, Japan.
Chommanart ThongkittidilokFaculty of Bioscience and Bioindustry, Tokushima University, Tokushima, Japan.
Taro MitoFaculty of Bioscience and Bioindustry, Tokushima University, Tokushima, Japan.
Sayuri TomonariFaculty of Bioscience and Bioindustry, Tokushima University, Tokushima, Japan.
Fuminori TaniharaFaculty of Bioscience and Bioindustry, Tokushima University, Tokushima, Japan. f_tanihara@jichi.ac.jp.
Takeshige OtoiFaculty of Bioscience and Bioindustry, Tokushima University, Tokushima, Japan.
Tokushima University · JPGuangdong Ocean University · CNPrince of Songkla University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The specificity and efficiency of CRISPR/Cas9 gene-editing systems are determined by several factors, including the mode of delivery, when applied to mammalian embryos. Given the limited time window for delivery, faster and more reliable methods to introduce Cas9-gRNA ribonucleoprotein complexes (RNPs) into target embryos are needed. In pigs, somatic cell nuclear transfer using gene-modified somatic cells and the direct introduction of gene editors into the cytoplasm of zygotes/embryos by microinjection or electroporation have been used to generate gene-edited embryos; however, these strategies require expensive equipment and sophisticated techniques. In this study, we developed a novel lipofection-mediated RNP transfection technique that does not require specialized equipment for the generation of gene-edited pigs and produced no detectable off-target events. In particular, we determined the concentration of lipofection reagent for efficient RNP delivery into embryos and successfully generated MSTN gene-edited pigs (with mutations in 7 of 9 piglets) after blastocyst transfer to a recipient gilt. This newly established lipofection-based technique is still in its early stages and requires improvements, particularly in terms of editing efficiency. Nonetheless, this practical method for rapid and large-scale lipofection-mediated gene editing in pigs has important agricultural and biomedical applications.

Indexed as

MutationAnimalsBlastocystCRISPR-Cas SystemsGene EditingLipidsMyostatinRibonucleoproteinsSwineTransfectionLipidsLipofectamineMyostatinRibonucleoproteins

Identifiers

PMID34903813
PMCPMC8668999
OpenAlexW4200077545

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.